Prof. Sir Michael Rawlins, Chairman, National Institute of Clinical Excellence, UK
Dr. Paul Smit, Senior Vice President, Philips Medical Systems
Dr. Philippe Cleuziat, Strategy Management Director, Molecular Biology, bioMérieux
Dr. Leonard Fass, Director, Academic Relations, GE Healthcare
Dr Arne Hengerer, Director, Molecular MRI, Siemens Medical Solutions
Dr. Kim Kreilgaard, Head of Division, European Investment Bank
Dr Thomas. K. Epprecht, Senior Risk Specialist, Swiss Reinsurance Company
Dr Ogan Gurel, CEO, Duravest inc
Dr. Dale Athey, Managing Director, Orla Protein Technologies Ltd
Dr. Peter Corish, Applications Manager Biodiagnostics, Oxonica Healthcare
Dr. Mathew Cooper, CEO, Akubio Ltd.
Dr. Eugene Seymour, CEO, Nanoviricides Inc.
Dr. AG Schätzlein, Founder and CSO, Nanomerics
Dr. Neil Butler, CEO, Vivacta
Del Stark, CEO, European Nanotechnology Trade Alliance
Dr. Jas Pal Badyal, Surface Innovation Technologies
Dr. Robert Muir, Director and co-founder of Innospan Ltd
Dr. Bob Irving, Scientific and Commercial Director, Nanotechnology Victoria Pty Ltd
Hlton Lord, Partner, Marks and Clerk |